Cardio Diagnostics Holdings (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, has released a new edition of its "State of Rural Hospitals and Cardiovascular Care" report. The report aims to equip rural healthcare leaders, policymakers, and community-based organizations with strategies to enhance cardiovascular care quality and outcomes in underserved areas.
The updated report sheds light on persistent challenges facing rural communities, including shortages of specialists and physicians, limited broadband access, and a higher prevalence of cardiovascular disease risk factors. These issues are compounded by geographic barriers that often delay timely diagnosis and treatment. The report presents a comprehensive four-part care model designed to address these gaps. The model emphasizes upskilling primary care clinicians to manage cardiovascular conditions more effectively, advancing care through epigenetic-genetic testing for early detection and personalized treatment, implementing population-wide health strategies to mitigate risk factors, and integrating remote care options to bridge access gaps.
Cardio Diagnostics highlighted the role of emerging technologies in transforming rural cardiovascular care. Virtual cardiac care and precision-medicine testing are positioned as key tools to strengthen early detection, improve access, and deliver personalized care. The report underscores how these innovations can help overcome the limitations of traditional care models in rural settings, where specialist availability is often scarce.
The release of this report comes at a critical time when cardiovascular disease remains a leading cause of mortality in the United States, with rural populations disproportionately affected. By focusing on actionable strategies, the report aims to support healthcare providers and policymakers in implementing sustainable improvements. The inclusion of epigenetic-genetic testing aligns with Cardio Diagnostics' core mission to leverage its proprietary AI-driven Integrated Genetic-Epigenetic Engine to make cardiovascular disease prevention, detection, and management more accessible and precise.
For more details, the full press release is available at https://ibn.fm/H28lM. Additionally, the latest news and updates regarding Cardio Diagnostics can be found in the company's newsroom at https://ibn.fm/CDIO.
